Mounting evidence suggests that hypertension is strongly linked to a variety of lipoprotein metabolism abnormalities. Apolipoprotein E gene (ApoE) is one such candidate with its common e2/e3/e4 polymorphism ranking high in hypertension association. To derive more specific information, we pinpoint our research scope in Chinese to test whether this polymorphism is associated with hypertension via a meta-analysis. Random-effects model was performed irrespective of the between study heterogeneity. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Overall, 12 studies with 14 study groups totalling 1532 hypertensive patients and 2172 controls were identified. Carriers of ApoE e2 allele had no significant increased risk for hypertension (pooled odds ratio (OR) ¼ 1.04; 95% confidence interval (CI): 0.80-1.35; P ¼ 0.78), compared with those carrying e3 allele, whereas those with e4 allele had a significant increased risk for hypertension (pooled OR ¼ 2.03; 95% CI: 1.61-2.55; Po0.00001). After excluding those with other small nationalities, we observed comparison of ApoE e2 with e3 allele yielded a pooled OR of 0.99 (95% CI: 0.82-1.19; P ¼ 0.89) among Han Chinese, and that of e4 with e3 yielded a pooled OR of 1.99 (95% CI: 1.48-2.67; Po0.00001). The fail-safe number at the level of 0.05 supported these significant associations. Taken together, our results expand previous findings and show that ApoE e4 allele is associated with a twofold increased risk of developing hypertension in Chinese.
Introduction
In China, the prevalence of hypertension among adults reached 18% in 2002, and it was significantly higher in urban compared with rural areas, 1 whereas latest statistics have yielded an exceedingly high prevalence of 30.6% among rural residents of Shandong province in 2007. 2 Given that hypertension is a major risk factor for cardio/cerebro-vascular diseases, its prevention remains an important public health goal. 3 Except for initiating healthy lifestyles such as low dietary salt intake and regular physical activity, an optimal prevention strategy is to identify and characterize hypertension susceptible genes, which might contribute to the diagnosis, prevention and treatment of this disorder.
Mounting evidence suggests that hypertension is strongly linked to a variety of metabolic abnormalities in lipoproteins and their encoded genes or variants are regarded as potential targets for evaluating the biological mechanism linked to hypertension susceptibility. 4 Apolipoprotein E (protein: ApoE and gene: ApoE) gene is one such candidate with its common e2/e3/e4 polymorphism ranking high in hypertension association. The e2, e3 and e4 differ in primary structure from one another at two substitution sites, site A (residue 112) and site B (residue 158). At sites A/B, ApoE e2, e3 and e4 contain cysteine/cysteine, cysteine/arginine and arginine/arginine, respectively. Functional studies showed that ApoE structural defects might result in an impaired interaction of ApoE containing lipoproteins with their receptors, and thus induce the development of atherogenic dyslipidaemias and premature cardiovascular diseases. 5 In addition, ApoE knockout mice exhibited hypertension and endothelial dysfunction. 6 Furthermore, a large panel of genetic studies associating ApoE e2/e3/e4 polymorphism with hypertension have been conducted across different ethnic groups, whereas the results are often irreproducible. 7 Accordingly, more and more geneticists insist on the construction of a hypertension genebank in each ethnic group. 3 To address this issue and generate more information, we here pinpoint our research scope in Chinese to test whether ApoE e2/e3/e4 polymorphism is associated with hypertension via conducting a comprehensive meta-analysis.
Methods
Literature search Three international searching engines, viz PubMed, EMBASE and Web of Science, as well as CBM or China Biological Medicine (http://cbmweb1. imicams.ac.cn/index.jsp) as the biggest Chinese biomedical database, were employed for collecting both English and Chinese publications with the last update as of June 5, 2010. All eligible reports were restricted to human studies in Chinese populations. Searching keywords included 'apolipoprotein E' or 'apoE' or 'apo E' and 'hypertension' or 'blood pressure', combined with 'gene' or 'variant' or 'polymorphism' or 'genotype' or 'allele' in each engine. Moreover, the reference lists of all retrieved articles were checked for other eligible reports that have not been identified as aforementioned. Where studies on the same cases or control subjects had been reported more than once, the most complete was included. Where studies included more than one geographical or ethnic population, each population was considered separately.
Inclusion and exclusion criteria
Studies satisfying the following criteria were identified: (i) evaluation of ApoE e2/e3/e4 polymorphism with hypertension; (ii) retrospective case-control studies using either a hospital-based or a population-based design; (iii) definition of hypertension as systolic (or diastolic) blood pressure X140 mmHg (or 90 mmHg) or treatment with antihypertensive medication; (iv) without consanguinity in cases and controls; (v) sufficient information upon genotype counts between cases and controls for estimating the odds ratio (OR) and its corresponding 95% confidence interval (CI). Besides, studies that focused on juvenile hypertension or secondary forms of hypertension such as pregnancy-induced hypertension were excluded from the present study.
Extracted information
Two authors (W-Q Niu and Y Qi) of this article independently drew the following information from all eligible studies: first author's last name, year of publication, ethnicity of the population studied, study design, number of subjects in each category, baseline characteristics of the study population and the counts of persons with different genotypes in cases and controls. Hardy-Weinberg equilibrium law was congruously tested for each population in both cases and controls. If combinational genotype data were provided in case of minimal variability of mutant alleles, information on Hardy-Weinberg equilibrium was tracked from the articles. At last, any encountered discrepancies were adjudicated by a discussion and a consensus was reached. For the sake of consistency, continuous variables such as age that were expressed as mean±standard error (s.e.) were converted as mean±s.d.
Statistical analysis
The open-source Review Manager software (version 5.0.19) (http://www.cc-ims.net/revman/download) was used for meta-analyses. The Hardy-Weinberg equilibrium was assessed by the w 2 -test (R software version 2.9, available at www.R-project.org) for studies without tracks.
Generally, the fixed-effects model was used in the absence of between-study heterogeneity (the Cochran's Q and I 2 statistics) and otherwise the random-effects model. 8 In this meta-analysis, we implemented the random-effects model only to bring the individual effect-size estimates together. This is mainly because within a fixed-effects model, only sampling error contributes to the differences between the observed effect-size estimates across individual studies. 9 In contrast, there are two sources of variance coexisted in a random-effects model including the sample error and betweenstudy heterogeneity. Given the ubiquitous nature of heterogeneity between studies, it is appropriate to utilize a random-effects model. 10 In addition, subgroup or sensitivity analyses were conducted to seek more narrowly drawn subsets of the studies by removing an individual study each time or studies with the similar features such as deviations from Hardy-Weinberg equilibrium to assess their individual effects.
Finally, we assessed the publication bias using the fail-safe number (N fs ) with the significance set at 0.05 for each meta comparison. In detail, if the calculated N fs value was smaller than the number of observed studies, the meta-analysis results might run the risk of having publication bias. We calculated the N fs0.05 according to the formula N fs0.05 ¼ ( P Z/1.64) 2 -k (k is the number of articles included in the meta-analysis).
Results
Baseline characteristics of all eligible studies As we focused our interest only to Chinese population and China is a multinational country, we accordingly classified study groups according to both areas (see details in Supplementary Figure) and nationalities. Shown in Table 1 is the description of population characteristics of all eligible studies in this meta-analysis. Considering the widely accepted fact that genetic heterogeneity across different ethnic or national groups is presented in most studies and the Han population accounts for over 90% in China, we regarded those study groups without national information and not in the small minority compact provinces such as Yunan and Guangxi provinces as Han Chinese.
Overall, 12 studies with 14 study groups totalling 1532 hypertensive patients and 2172 controls were identified in this meta-analysis according to the inclusion/exclusion criteria. 4, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] All study groups were from seven provinces of China including Shandong (n ¼ 2), 12, 18 Hubei (n ¼ 1), 15 Hunan (n ¼ 1), 16 Jiangsu (n ¼ 1), 19 Hebei (n ¼ 3), 4, 15, 20 Xinjiang (n ¼ 1), 11 Tibet (n ¼ 3) 14 and Guangxi (n ¼ 2). 13, 21 With regard to allele frequency, wide differences were noted for each allele of ApoE e2/ e3/e4 polymorphism. For example, ApoE e4 allele ranged from 6.9 to 52.1% in hypertensive patients and from 1.5 to 42.7% in controls across all study groups.
Meta-analysis of allele association As for allele association, carriers of ApoE e2 allele had a 4% nonsignificant increased risk for hypertension (pooled OR ¼ 1.04; 95% CI: 0.80-1.35; P ¼ 0.78), compared with those carrying e3 allele (Figure 1) . Interestingly, one Tibetan group favoured strikingly protective effect of e2 allele with a 87% decreased risk (95% CI: 0.03-0.59).
14 Contrastingly, another group of Han ethnicity from the same region showed a widely divergence trend with e2 allele conferring a significant 2.81-fold increased risk (95% CI: 1.03-7.64). 14 In addition, compared with ApoE e3 allele carriers, those with e4 allele had a significant increased risk for hypertension (pooled OR ¼ 2.03; 95% CI: 1.61-2.55; Po0.00001) (Figure 2 ). Except for one study with odds risk nearly approaching the unity (OR ¼ 0.99), 12 others consistently indicated the risk effect of this allele with odds ratios between 1.53 15 and 6.63.
13
Meta-analysis of genotype association As suggested by Kesäniemi et al., because of the opposite net effect between ApoE e2 and e4 alleles, genotype e2/e4 should be excluded from the genotype analysis. 22 We thus discarded ApoE e2/e4 genotype and found that the protective effect of e2/e2 and e2/e3 genotypes was weakened by 14.5% (pooled OR ¼ 0.87; 95% CI: 0.68-1.11; P ¼ 0.27) (Figure 3 ) and the risk effect of e3/e4 and e4/e4 genotypes was strengthened by 12.3% (pooled OR ¼ 2.19; 95% CI: 1.62-2.98; Po0.00001) (Figure 4 ).
Subgroup analysis
Considering the fact that Han nationality constitutes the majority of China's people, after excluding those with other small nationalities, we observed the comparison of ApoE e2 with e3 allele yielded a pooled OR of 0.99 (95% CI: 0.82-1.19; P ¼ 0.89) among Han Chinese, and that of e4 with e3 allele generated a pooled OR of 1.99 (95% CI: 1.48-2.67; Po0.00001). As for genotype association, compared with e3/e3 genotype, carriers of e2/e2 and e2/e3 genotypes had a 15% decreased risk (95% CI: 0.66-1.11; P ¼ 0.24), whereas these with e3/e4 and e4/e4 genotypes had a significant 99% increased risk (95% CI: 1.44-2.75; Po0.0001) for hypertension among Han Chinese. 
Publication bias
In order to assess the publication bias, we calculated the N fs at the significance level of 0.05 for each comparison. The N fs0.05 values for all the contrasts were greater than the number of studies included in this meta-analysis.
Discussion
This meta-analysis, focusing on only Chinese populations and including 1532 hypertensive patients and 2172 controls, investigated the association of ApoE e2/e3/e4 polymorphism with hypertension. The most noteworthy finding was that ApoE e4 allele conferred a twofold increased risk of developing hypertension, which was in agreement with the results from a recent meta-analysis performed in English publications. 7 Moreover, after restricting the study group to Han Chinese, this association still persisted. Furthermore, there was no publication bias by using the fail-safe number, indicating the robustness of this meta-analysis.
Currently, although great efforts have been taken to explore the genetic susceptibility of candidate variation to hypertension, there is a considerable Figure 1 Random-effects based OR of developing hypertension for ApoE e2 allele carriers versus the e3 allele carriers. Figure 2 Random-effects based OR of developing hypertension for ApoE e4 allele carriers versus the e3 allele carriers.
ApoE and hypertension: a meta-analysis W-Q Niu and Y Qi degree of non-reproducibility in most of these studies, which may be due to too small study groups and genetic heterogeneity of the study populations. As suggested, to generate robust data, a much larger sample involving 41000 subjects in each group might be required, and often more it depends on the prevalence of the polymorphism under study. 23 For most genetic association studies, such a large sample size is usually an unrealistic goal. To reach a satisfactory power, meta-analysis of multiple studies clearly has a role in offering an association with such potentials. 24 Moreover, considering different genetic backgrounds among different races and ethnic groups, 7 it is necessary to construct a database of polymorphisms related to hypertension in each ethnic group. One potential strategy to lessen the genetic heterogeneity is to pinpoint the research scope to a single ethnic group.
Bearing these in mind, we here performed a comprehensive meta-analysis in Chinese associating ApoE e2/e3/e4 polymorphism with hypertension. The presence of this polymorphism was identified Figure 3 Random-effects based OR of developing hypertension for ApoE e2/e2 and e2/e3 genotype carriers versus the e3/e3 genotype carriers. Figure 4 Random-effects based OR of developing hypertension for ApoE e3/e4 and e4/e4 genotype carriers versus the e3/e3 genotype carriers. more than 30 years ago by Utermann et al., 25 and this polymorphism, as a potential candidate, has been linked to a wide range of complex diseases such as Alzheimer's disease, 26 macular degeneration, 27 stroke, 28 hypertension 4, 20, 21 and so on. Besides, some animal studies provided evidence that ApoE was functional in lipoprotein metabolism. Even though, the exact mechanism underlying ApoE e2/e3/e4 polymorphism still remains unclear. However, in Chinese, we found that compared with e3 allele, ApoE e4 allele consistently showed an increased risk for hypertension across different national groups, even within Han Chinese individuals, although the frequencies of e4 allele differed greatly in different study groups. For example, in this metaanalysis, ApoE e4 allele ranged from 6.9 to 52.1% in hypertensive patients and from 1.5 to 42.7% in controls across all study groups. It is thus reasonable to speculate that if involved, ApoE e2/e3/e4 polymorphism may be a logical candidate variant for involvement in the underlying cause of hypertension. Moreover, given the modest OR estimates and wide confidence intervals due to small sample sizes, we cannot exclude the possibility of chance finding and spurious association between ApoE e2/e3/e4 polymorphism and the risk of hypertension. Therefore, the jury must refrain from drawing a conclusion until a large, well performed Chinese study confirms or refuses our results.
This study has some limitations meriting serious consideration. First, all included studies had the cross-sectional design, which precludes further comments on causality. Second, in this study, we only focused on hypertension as a categorical trait rather than the continuous blood pressure form, which runs the risk of losing some information. Third, due to the relative small number of the eligible studies, we were unable to perform further subgroup analyses such as by gender because of limited data. Fourth, we cannot retrieve information upon various confounding factors such as smoking, drinking from all these original publications, which have been regarded as effective modulators for the development of hypertension. Last but not the least, because studies in other Chinese small nationalities are relatively few and constitute small sample sizes, we cannot have enough power to decipher the firm association of ApoE e2/e3/e4 polymorphism with hypertension in these nationalities. It is anticipated that large studies in Chinese small nationalities are encouraged to fully fill this void.
In summary, this meta-analysis extended previous findings on the association between ApoE e2/e3/e4 polymorphism and hypertension in Chinese by showing that the e4 allele was associated with a significantly increased hypertension risk, although there was wide range of allele frequencies. Further studies should investigate ApoE e2/e3/e4 adjacent markers to confirm whether this association is causal or due to linkage disequilibrium.
